Colorado has taken the lead in controlling prescription drug costs by setting a payment limit for the arthritis drug Enbrel, which costs insurers an average of $46,772 per patient per year. This move may signal a new era of state governments actively working to control the rising costs of prescription medications. While the state board has yet to determine the exact payment limit for Enbrel, this decision marks the first time Colorado has deemed a drug unaffordable for its patients. This development could set a significant precedent for other states looking to tackle the issue of expensive prescription drugs.
Source link
Amgen drug Enbrel will see price limit in Colorado
